FABIANI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 3.224
AS - Asia 2.625
EU - Europa 2.531
SA - Sud America 414
Continente sconosciuto - Info sul continente non disponibili 236
AF - Africa 149
OC - Oceania 1
Totale 9.180
Nazione #
US - Stati Uniti d'America 3.029
IT - Italia 1.145
SG - Singapore 787
RU - Federazione Russa 723
CN - Cina 651
BR - Brasile 319
VN - Vietnam 287
BD - Bangladesh 280
HK - Hong Kong 179
KR - Corea 179
DE - Germania 97
FR - Francia 97
CA - Canada 95
IN - India 89
IE - Irlanda 85
GB - Regno Unito 84
FI - Finlandia 82
ZA - Sudafrica 69
NL - Olanda 47
MX - Messico 35
SE - Svezia 31
AR - Argentina 30
ES - Italia 28
TR - Turchia 23
PL - Polonia 22
IQ - Iraq 21
KE - Kenya 20
CI - Costa d'Avorio 19
IL - Israele 16
VE - Venezuela 16
LT - Lituania 15
CZ - Repubblica Ceca 14
JP - Giappone 13
AT - Austria 12
CO - Colombia 12
SV - El Salvador 12
EC - Ecuador 11
ID - Indonesia 11
UA - Ucraina 11
JM - Giamaica 10
PK - Pakistan 10
SA - Arabia Saudita 10
SC - Seychelles 10
PY - Paraguay 9
TT - Trinidad e Tobago 9
UZ - Uzbekistan 9
HN - Honduras 8
CR - Costa Rica 7
IR - Iran 7
BE - Belgio 6
DZ - Algeria 6
MA - Marocco 6
PH - Filippine 6
BY - Bielorussia 5
CL - Cile 5
EG - Egitto 5
KZ - Kazakistan 5
LB - Libano 5
MY - Malesia 5
CW - ???statistics.table.value.countryCode.CW??? 4
GP - Guadalupe 4
GR - Grecia 4
GT - Guatemala 4
GY - Guiana 4
PE - Perù 4
PR - Porto Rico 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
DK - Danimarca 3
JO - Giordania 3
LV - Lettonia 3
NP - Nepal 3
TN - Tunisia 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
LI - Liechtenstein 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TM - Turkmenistan 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
CG - Congo 1
CM - Camerun 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GI - Gibilterra 1
Totale 8.936
Città #
Dallas 530
Singapore 463
Milan 327
San Jose 313
Hefei 294
Moscow 216
Santa Clara 211
Ashburn 209
Council Bluffs 198
Seoul 177
Hong Kong 169
Rome 158
New York 106
Los Angeles 101
Ho Chi Minh City 98
Beijing 96
Dublin 82
Hanoi 82
Johannesburg 63
Lauterbourg 57
The Dalles 50
Siena 49
Florence 43
Munich 43
Columbus 41
Lappeenranta 40
Buffalo 38
Bengaluru 36
Orem 35
Chicago 34
Helsinki 32
Naples 30
São Paulo 27
Toronto 25
Turin 25
Frankfurt am Main 23
Phoenix 23
Chennai 22
Redondo Beach 22
Abidjan 19
Montreal 19
Warsaw 19
North Bergen 18
Atlanta 16
Da Nang 16
London 16
Brooklyn 15
Florissant 15
Seattle 15
Cedar Knolls 14
Figino 14
Pisa 14
Bologna 13
Mexico City 13
Manchester 12
Amsterdam 11
Belo Horizonte 11
Messina 11
Miami 11
Palermo 11
Tokyo 11
Bari 10
Denver 10
Haiphong 10
Modena 10
Newark 10
San Salvador 10
Shanghai 10
Stockholm 10
Turku 10
Washington 10
Baghdad 9
Madison 9
San Francisco 9
Wilmington 9
Boardman 8
Düsseldorf 8
Istanbul 8
Maple Grove 8
Mumbai 8
Perugia 8
Rio de Janeiro 8
Brasília 7
Charlotte 7
Houston 7
Jacksonville 7
Pamplona 7
Philadelphia 7
Portsmouth 7
Reggio Emilia 7
Southend 7
Tashkent 7
Tehran 7
Vilnius 7
Biên Hòa 6
Boston 6
Brescia 6
Campinas 6
Catania 6
Clifton 6
Totale 5.214
Nome #
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 354
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 253
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs) 242
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 237
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network 223
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 219
Diagnostic accuracy of OGUS, Southend halo score and halo count in giant cell arteritis 209
Development and implementation of the AIDA international registry for patients with non-infectious scleritis 208
A fluffy white retinal lesion in a woman with spondyloarthritis treated with tofacitinib 202
Color Doppler Eye Ultrasonography in giant cell arteritis: differential diagnosis between arteritic and non-arteritic sudden blindness 198
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 198
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry 196
Purtscher-like retinopathy in a patient with systemic tacrolimus vasculopathy 192
Development and implementation of the International AIDA Network Castleman’s disease registry 178
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry 173
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 167
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still's Disease Registry 166
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network 163
Development and implementation of the international AIDA network spondylarthritis registry 157
Uveitis: A snapshot in the MOG antibody spectrum 157
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry 153
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 151
Safety and Efficacy of Long-Term Tocilizumab in a Cohort of Patients with Giant Cell Arteritis: An Italian Monocentric Retrospective Study 150
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA network registries 149
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 146
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries 146
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study 145
Evidence and Consensus-based Multimodal Imaging Guidelines in Birdshot Chorioretinopathy - Multimodal imaging in Uveitis (MUV) Taskforce Report 8 141
The current status of biological treatment for uveitis 135
Evidence and Consensus-Based Imaging Guidelines in Noninfectious Posterior Uveitis—Methodology of the Multimodal Imaging in Uveitis (MUV) Project Report 2 134
Knowledge and Current Practices in Monogenic Uveitis: An International Survey by IUSG and AIDA Network 132
Validity of machine learning in predicting giant cell arteritis flare after glucocorticoids tapering 130
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis 128
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry 127
Imaging findings in patients with axial spondyloarthritis presenting with recurrent fever attacks: data from the international AIDA network spondyloarthritis registry 124
Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice 117
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 112
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry 109
Efficacité de l'anakinra dans la polysérite réfractaire : étude multicentrique italienne [Efficacy of anakinra in refractory polyseritis: Italian multicenter study] 109
Systemic auto-inflammatory manifestations in patients with spondyloarthritis 107
Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseases 105
Evidence and Consensus Based Guidelines for Imaging in Serpiginous Choroiditis - Multimodal imaging in Uveitis (MUV) Taskforce: Report 4 105
Standardization of OCT Angiography Nomenclature in Retinal Vascular Diseases 103
Editorial: Global excellence in inflammatory eye diseases: Europe 103
Combined central retinal artery and vein occlusion as first act of varicella-zoster virus acute retinal necrosis 103
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry 101
Rheumatologist’s Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 100
Routine color doppler ultrasonography for the early diagnosis of cranial giant cell arteritis relapses 100
Efficacy and safety of rituximab and low dosage of glucocorticoids for ANCA associated vasculitis interstitial lung disease: a proof-of-concept study 99
Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry 98
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry 97
Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study 97
Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry 93
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 89
Evidence and Consensus Based Guidelines for Imaging in Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE) - Multimodal imaging in Uveitis (MUV) Taskforce: Report 7 85
VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries 82
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 82
Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis Registry 81
Ocular and nasopharyngeal manifestations of mantle cell lymphoma: a multidisciplinary approach to diagnosis and treatment challenges 78
IgG4-related disease presenting as hypertrophic pachymeningitis 77
Evidence and Consensus-Based Imaging Guidelines in Multifocal Choroiditis With Panuveitis and Punctate Inner Choroiditis—Multimodal Imaging in Uveitis (MUV) Taskforce Report 5 75
Tocilizumab effectiveness in paediatric non-infectious uveitis: data from the International AIDA Network Registries on ocular inflammatory disorders 73
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries 71
Evidence and Consensus Based Imaging Guidelines in Multiple Evanescent White Dot Syndrome Multimodal imaging in Uveitis (MUV) Taskforce Report 6 67
Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry 66
A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian study 52
Minimum Imaging Sets for Diagnosis, Activity Assessment, and Complications in Noninfectious Posterior Uveitis - Multimodal Imaging in Uveitis (MUV) Task Force Report 9 41
Systematic Review of Clinical Utility of Multimodal Imaging in Noninfectious Posterior Uveitis: MUV Project Report 3 40
Organ damage is a major determinant of work productivity impairment in Behçet's syndrome: a post hoc analysis of the BODI validation study 28
Long-term remission and monocyclic course in Still’s disease patients starting canakinumab early: data from the international AIDA network registry 26
Risk of intestinal involvement in mucocutaneous-onset Behçet’s disease: data from the AIDA network registry 26
Totale 9.180
Categoria #
all - tutte 25.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.870


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 0 0 0 0 0 0 1 4 3 1 3 3
2022/202344 1 1 3 1 0 18 3 1 7 1 7 1
2023/2024240 5 3 18 12 8 46 58 11 6 5 13 55
2024/20251.578 27 52 180 60 180 104 62 79 102 73 165 494
2025/20265.601 366 660 510 656 845 206 551 219 210 360 351 667
2026/20271.673 351 354 347 431 190 0 0 0 0 0 0 0
Totale 9.180